Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

SABCS 2020 | Upcoming data from SABCS 2020

Ivana Sestak • 10 Dec 2020
SABCS 2020
Breast Cancer
RxPONDER

Ivana Sestak, PhD, Wolfson Institute of Preventive Medicine, Queen Mary University London, London, UK, discusses upcoming updates from the San Antonio Breast Cancer Symposium (SABCS) including the results from the RxPONDER study. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

More from Ivana Sestak

1:04
Strategies to improve wellbeing in breast cancer patients
Ivana Sestak • 10 Dec 2020
1:17
Future advances in DCIS: de-escalation of hormonal therapy
Ivana Sestak • 10 Dec 2020
3:04
12-year results of anastrozole vs tamoxifen for breast cancer prevention
Ivana Sestak • 10 Dec 2020

Related Videos

4:12
PETRA: saruparib in solid tumors with BRCA1/2, PALB2 or RAD51C/D mutations
Timothy Yap • 7 Apr 2024
1:03
The future of peptide-conjugated drugs in oncology
Mitchell Elliott • 8 Apr 2024
1:26
The clinical applications of MRD in breast cancer
Mitchell Elliott • 8 Apr 2024
1:47
CCNG1 as a biomarker for DRG-101 gene therapy in cancer
Vaishali Kumar • 8 Apr 2024
The content of VJOncology is intended for healthcare professionals